MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

MC

556.9

-3.33%↓

SANES

6.177

-1.92%↓

BNP

75.4

-1.39%↓

CS.FR

39.95

-0.77%↓

ALV

356.3

+0.06%↑

Search

Eurazeo SE

Open

SectorFinance

65.6 -2.45

Overview

Share price change

24h

Current

Min

64.25

Max

67.45

Key metrics

By Trading Economics

Income

-105M

Sales

104M

Dividend yield

3.89

Profit margin

-100.723

EBITDA

-51M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+44.93% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.89%

3.90%

Next Earnings

10 kwi 2025

Market Stats

By TradingEconomics

Market Cap

5.1B

Previous open

68.05

Previous close

65.6

News Sentiment

By Acuity

41%

59%

172 / 542 Ranking in Finance

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Eurazeo SE Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 wrz 2024, 06:28 UTC

Acquisitions, Mergers, Takeovers

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Peer Comparison

Price change

Eurazeo SE Forecast

Price Target

By TipRanks

44.93% upside

12 Months Forecast

Average 100 EUR  44.93%

High 100 EUR

Low 100 EUR

Based on 1 Wall Street analysts offering 12 month price targets forEurazeo SE - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

N/A / 71.95Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

172 / 542 Ranking in Finance

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil